Oncologist-mammologist

Treatment of mastopathy, which causes pain and swelling of the mammary gland

Treatment of large breast cysts without surgical aspiration

Treatment of duct ectasia (dilation) and galactorrhea

Obtaining a smear from the secretion of the mammary gland

Treatment of adenosis and other precancerous diseases of the mammary gland

Biopsy of pathological formations on the skin of the mammary gland

Hormonal treatment for breast cancer

Treatment of precancerous diseases of other organs

Cancer Treatment

Symptomatic treatment of cancer patients

Mistletoe therapy and cancer treatment with high doses of vitamin C.

Elimination of complications and side effects of chemotherapy and radiation therapy

Pain Treatment for Cancer Patients (Natural Pain Relief and Life Extension)

Participant of many conferences and seminars with the participation of German doctors in Azerbaijan, as well as in Germany and Turkey.

Prof. Zvi Cohen is Director of the Neurosurgery Department and the Neuro-Oncology Unit at Sheba Medical Center. He is a neurosurgeon and neuro-oncology expert. He was included in Forbes Israel’s Best Doctors 2025. He leads clinical research on drug therapies for malignant brain tumors. He also founded Sheba’s brain tumor tissue bank.

He is board-certified in neurosurgery. He trained at Tel Aviv University. He completed fellowships in neuroradiology at Beth Israel and in neurosurgical oncology at MD Anderson. His practice covers complex brain, pituitary, spine, and spinal cord tumors. He has expertise in stereotactic biopsies, image-guided resections, intraoperative MRI, navigation systems, and radiosurgery. He is a member of the Society for Neuro-Oncology and the Israeli Association of Neurological Surgeons.

Prof. Amit Tirosh is a senior endocrinologist and Head of the Neuroendocrine Tumors Service at Sheba Medical Center. He specializes in neuroendocrine tumors (NETs).

His work centers on hereditary NET syndromes. He is affiliated with the NIH in MEN1 research. He serves on an international VHL expert panel and helped write VHL management guidelines. He is the primary contact at Sheba’s multidisciplinary VHL clinic.

He leads the Endocrine Oncology Bioinformatics Lab. He collaborates with international teams, including the Weizmann Institute. He provides advanced NET care, including PRRT.

He earned his MD from the Hebrew University–Hadassah. He completed a residency at Assaf HaRofeh, an endocrinology fellowship at Rabin, and training at the NIH. He is board-certified in Endocrinology. He is a member of the Israeli Society of Endocrinology, the Endocrine Society, and the European Neuroendocrine Tumor Society. He has authored over 40 peer-reviewed papers, including in JAMA, Gastroenterology, and Radiology.

Dr. Einat Shacham‑Shmueli is a senior medical oncologist at the Gastrointestinal Clinic, Cancer Center, Sheba Medical Center. She treats cancers of the colon, stomach, and pancreas. She also manages metastatic disease. She uses precision diagnostics and biomarkers, systemic therapies, and radiotherapy. Care is provided within a multidisciplinary team.

She has authored more than 25 peer‑reviewed papers on GI oncology, tumor biology, and new treatments. Her work includes studies on stenting for malignant colonic obstruction. She serves as an investigator in international programs, including the NCI, the Radiation Therapy Oncology Group, and the Cancer Therapy Evaluation Program.

Education: MD, Tel Aviv University. Oncology residency, Tel Aviv Sourasky Medical Center. Advanced training in GI oncology, UCSF. Accreditations: Board certified in Oncology and Gastroenterology. Member, Israel Society of Oncology and Radiotherapy.

Professor Dov Zippel is a general surgeon and surgical oncologist. He specializes in breast disease and melanoma. He leads the Meirav Breast Center at Sheba Medical Center. He also serves at the Ella Lemelbaum Institute for Immuno-Oncology. In 2025, Forbes Israel named him to its Best Doctors list.

Expertise: advanced care for benign and malignant breast tumors. Minimally invasive and breast-conserving surgery. Surgical treatment of melanoma and other skin cancers.

Accreditations: MD, Tel Aviv University. Residency in general surgery, Sheba Medical Center. Fellowship in surgical oncology, University of Calgary. Board-certified in general surgery and surgical oncology. Research includes intact breast lesion excision and perioperative BRAF inhibitors for stage III melanoma.

Dr. Osama Abdel Mohimen Mohamed is Head of the Hematology Unit at Shefaa Al Orman Oncology Hospitals. He is also a consultant in medical oncology and hematology at Shefa El Orman Hospital (NGO), Luxor (2019–present).

He diagnoses and treats acute and chronic leukemia, lymphoma, myeloma, myelodysplastic syndromes, and myeloproliferative neoplasms. He also manages complications of solid tumors.

Background: He served at the National Cancer Institute, Cairo University, as a medical oncology resident, then demonstrator and assistant lecturer (2008–2022). Earlier, he was a house officer (2006–2007). He also held specialist roles at Al Salam International, Al Molalmen, and BAHEYA Oncology Center (NGO).

Memberships: ESMO (2008–present). American Society of Bone Marrow Transplantation (2009). ASH (2010).

Dr. Almog Ben-Yaacov is an Attending Surgeon in the Department of General and Oncological Surgery (Surgery C) at Sheba Medical Center. He specializes in cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC). His clinical focus includes gastric cancer, sarcoma, and complex colorectal malignancies. Since 2018, he has performed more than 200 HIPEC procedures.

MD, Semmelweis University, 2006, with honors. Training in cardiothoracic surgery at Sheba Medical Center. Residency in general surgery at Montefiore (Albert Einstein) and at Rabin (Beilinson). Board-certified in General Surgery and in Surgical Oncology.

Advanced training includes ESSO-certified HIPEC in Hamburg. Microwave liver ablation in Reims. NanoKnife at King’s College London. Advanced surgical oncology at Memorial Sloan Kettering (2019). His publications cover CRS+HIPEC outcomes and Hartmann’s reversal.

Dr. Shira Felder is a senior radiation oncologist. She focuses on gynecologic and urologic cancers. She has advanced expertise in VMAT, IMRT, SBRT, and gynecologic brachytherapy. She delivers precise treatment with fewer side effects.

She heads the Gynecologic Oncology Service at Sheba Medical Center. She is a senior physician in the Radiation Oncology Division. She earned her MD at Hadassah. She completed residency at Sheba and a fellowship in the Radiation Medicine Program at the University of Toronto and Princess Margaret Cancer Centre. She is board-certified in Radiation Oncology. She is a member of ESTRO, the Israeli oncology societies, the CPSO, and the CMA.

Her research covers brachytherapy patient safety. It also includes stereotactic ablative radiotherapy for stage I lung cancer. She has studied treatment delays in cervical cancer. She has examined vitamin D deficiency in oncology patients.

Dr. David Kuczer is a specialist in radio-oncology with many years of experience in cancer diagnosis and treatment. He offers fast access to precise radiotherapy based on current scientific standards.

He is a member of the Cancer Center at the Vienna Private Clinic. He presents each patient to the in-house tumor board. This allows an interdisciplinary discussion by an internationally renowned team and helps select the best treatment.

All radiation treatments are provided in close cooperation with Amethyst Radiotherapy at the Vienna Private Clinic.

アントニオ・アルカラス博士はテクノン医療センター（バルセロナ、スペイン）の泌尿器科および腎移植部門を率いています。

アントニオ・アルカラス博士は、30年以上の経験を持つスペインの有名な外科医、泌尿器腫瘍学者、移植専門医です。彼のマネジメントの下、泌尿生殖器系の病理を治療するために500を超える成功した手術が行われました。多くの外科的介入は、低侵襲技術（腹腔鏡による経膣的腎臓摘出術、腎摘出術、腎移植を含む）で行われました。アントニオ・アルカラスの主な専門分野は、前立腺癌の治療です。

腎臓、膀胱、副腎、精巣、尿管、および他の泌尿器系の臓器の腫瘍性疾患の治療は、ダ・ヴィンチ手術ロボットシステムを用いた伝統的な外科的方法および革新的な方法によって提供されます。

アントニオ・アルカラス博士はまた、たとえば停留精巣のような子供の先天性病態も治療します。

医師は下記のような権威ある専門コミュニティのメンバーです：

• アメリカ泌尿科連合；
• スペイン泌尿器科協会；
• 欧州泌尿器科学会。

Dr. Yahya Özel is a highly experienced general surgeon with expertise in bariatric surgery, hepatobiliary diseases, abdominal hernias, endocrine surgery, and oncological surgery. He completed his medical education at Istanbul University, Istanbul Faculty of Medicine in 1990 and pursued his specialization in General Surgery at Haydarpaşa Numune Training and Research Hospital between 2001 and 2006. His commitment to advanced surgical techniques led him to further training at Tokyo University Hospital, Japan, in the Hepato-Biliary-Pancreatic Surgery and Artificial Organ Division under renowned experts M. Makuuchi and N. Kokudo.

Throughout his career, Dr. Özel has worked at prestigious institutions, including Istanbul University Faculty of Medicine, Haydarpaşa Numune Training and Research Hospital, and Ümraniye Training and Research Hospital. His extensive experience includes roles in ERCP and surgical endoscopy, as well as advanced laparoscopic and robotic surgery. In addition to his clinical practice, he has served as an academic faculty member at Doğuş University, contributing to the education and training of future medical professionals.

Dr. Özel holds several certifications in surgical endoscopy, including the Turkish Surgical Proficiency Certificate. His dedication to minimally invasive surgical techniques, obesity treatment, and hepatobiliary surgery has made him a sought-after specialist in his field. With a career spanning over three decades, he continues to provide high-quality, patient-centered surgical care, ensuring the best outcomes through his expertise and innovative approach.

Personal information

Title: Professor Doctor

Branch: Radiation Oncology

Work History:

1 GATA Military Medical Faculty

2 Gayrettepe Florence Nightingale Hospital

3 T.R. Demiroğlu Bilim University \ Associate Professor

4 T.R Demiroğlu Bilim University \ Professor

Medical Specialties and Subspecialties:

1 Head and Neck Cancers

2 Radiation Oncology

Priority treatments:

1 Prostate cancer

2 Conformal treatments

Special advanced health technologies:

1 Truebeam Stx Technology

2 Halcyons

Education

1991 - Istanbul University Istanbul Faculty of Medicine

1996 - Istanbul University Cerrahpaşa Faculty of Medicine Radiation

Oncology Specialization Training

2023 – Istanbul Gaziosmanpaşa Taksim Education and Research Hospital – General Surgery Clinic Associate Professor

2013 – Istanbul Gaziosmanpaşa Taksim Education and Research Hospital – General Surgery Clinic Specialist

2008 – 2013 Private Medical Park Fatih Hospital, General Surgery Specialist - Deputy Chief Physician

2005 – 2007 Private Gelişim Hospital – General Surgery Specialist

2003 – 2005 Private Istanbul Şafak Hospital – General Surgery Specialist - Chief Physician

2002 – 2003 ISTANBUL HASEKİ EDUCATION AND RESEARCH HOSPITAL – General Surgery Clinic Assistant Physician

1998 – 2002 Ankara Education and Research Hospital – General Surgery Clinic Assistant Physician

1998 – Health Sciences University – Istanbul Haseki Health Application and Research Center – Medical Specialization

1991 – Gazi University Faculty of Medicine – Bachelor’s Degree

Certificates

IGM Diagnosis, Treatment Workshop, Granulomatous Mastitis, Kocaeli, Certificate, 07.10.2023 (National)

ibreast 51- Free Flap Reconstruction, Breast Cancer Surgery, Online, Certificate, 30.09.2023 – 30.09.2023 (International)

ibreast 50- Triple Negative Breast Cancer, Breast Cancer, Online, Certificate, 02.09.2023 -02.09.2023 (International)

ibreast 49- Implant Based Reconstruction, Breast Cancer, Online, Certificate, 12.08.2023 -12.08.2023 (International)

ibreast 48- DCIS, İbreast 48- DCIS, Online, Certificate, 15.07.2023 -15.07.2023 (International)

ibreast 47- Conference Updates, Breast Cancer, Online, Certificate, 25.06.2023 -25.06.2023 (International)

ibreast 46- Margin Revisited, Breast Cancer, Online, Certificate, 10.06.2023 -10.06.2023 (International)

1. International 4. National Breast Surgery Congress, Breast Surgery, Ürgüp, Certificate, 05.05.2023 – 07.05.2023 (International)

ibreast 44- HER2 Positive Disease, Breast Cancer, Online, Certificate, 29.04.2023 -29.04.2023 (International)

St-Gallen 2023, St-Gallen Congress Summary Meeting, Istanbul, Certificate, 01.04.2023 -01.04.2023 (National)

ibreast 43- Save The Nipple, Breast Cancer, Online, Certificate, 25.03.2023 -25.03.2023 (International)

ibreast 42-Chest Wall Perforator Flap Revisited, Breast Cancer, Online, Certificate, 25.02.2023 -25.02.2023 (International)

ibreast 41- High Risk And B3 Lesions, Breast Diseases, Online, Certificate, 28.01.2023 -28.01.2023 (International)

15. New Approaches in Breast Cancer Education Meeting, Breast Cancer, Istanbul, Certificate, 07.01.2023 – 08.01.2023 (National)

Articles she wrote and took part in;

1.YILDIRIM EMİNE, BEKTAŞ SİBEL, YETİŞ FIRAT, YILDIZ EREN OZAN, ÖZDEMİR MUHAMMED, KOMUT NESLİHAN, ÇALIK MUSTAFA, ER AHMET MUZAFFER. Correlation between breast and axillary pathologic complete response after neoadjuvant chemotherapy in breast cancer. Annali Italiani di Chirurgia, 2023

2.UZUN NEDİM, YILDIRIM EMİNE. Relationship Between Toilet Type and Hemorrhoids. Bezmialem Vakif University, 2022

3.YILDIZ EREN OZAN, YILDIRIM EMİNE, ORHUN ERDOĞAN KIVILCIM, ERYILMAZ İKLİL, YÜNLÜEL EMİR MEHMET, YETİŞ FIRAT, ULUKENT SUAT CAN. The effect of the covid 19 pandemic on the number of patients treated for acute and complex acute appendicitis. Annali Italiani di Chirurgia, 2202

4.YILDIRIM EMİNE, BEKTAŞ SİBEL, ÖZDEMİR MUHAMMED, KARAGÜLLE AHENK, ER AHMET MUZAFFER, UÇAR NEŞE. Upgrade Rates of DCIS, Intraductal Papilloma, and the Other High-risk Breast Lesions. Hamidiye Medical Journal, 2022
 

5.ÖZKAN GÜMÜŞKAYA PERİHAN, ALTUN ÖZGÜR, KARAKÜTÜK YÜZTAŞ NUR, ÖZSOY NESLİHAN, AYDIN TUTAK GÜLTEN, YILDIRIM EMİNE, ADAŞ MİNE, KÜÇÜK MEHMET. COVID-19 Pnömonisi Sonrası AntiHBs Değerlerindeki Değişiklikler. Journal of Contemporary Medicine, 2022;12(4), 

6.KOMUT NESLİHAN, BEKTAŞ SİBEL, YILDIRIM EMİNE. The relationship of tumor budding with GOLPH3 expression and histopathological prognostic parameters in colorectal adenocarcinoma. Annals of Diagnostic Pathology 2022 Jun;58:151933. 

7.KAYADİBİ YASEMİN, UÇAR NEŞE, AKAN YEŞİM NAMDAR, KAYA MEHMET FATİH, YILDIRIM EMİNE, ALADAĞ KURT SEDA, SOYLU BOY FATMA NUR, TAŞKIN FÜSUN, İÇTEN GÜL ESEN. Magnetic resonance imaging findings associated with recurrence in idiopathic granulomatous mastitis. Clinical Imaging, 2022

8.YILDIRIM EMİNE, KEĞİN MURAT, ÖZDEMİR MUHAMMED, BEKTAŞ SİBEL, PELEN ZEKERİYA, ER AHMET MUZAFFER. Neoplasms of theAppendix; Single Institution and Ten-Year Experiences Results. Turkish Journal of Trauma and Emergency Surgery, 2022;28(3), 352-360

9.YILDIRIM EMİNE, YILDIZ EREN OZAN, ERYILMAZ İKLİL, ER AHMET MUZAFFER, BEKTAŞ SİBEL. Comparison of excised breast volume, re-excision rate and margin positivity in breast-conserving surgery in breast cancer patients using and not using neoadjuvant chemotherapy. Journal of Surgery in Medicine,2022;6

10.YILDIRIM EMİNE, BEKTAŞ SİBEL, PELEN ZEKERİYA, YANIK İREM, ER AHMET MUZAFFER, ÇENGEL FERHAT, ÖZKAN GÜMÜŞKAYA PERİHAN. Histopathological, Radiological, and Demographic Factors Predicting the Response to Neoadjuvant Therapy for Rectal Cancer. Journal of Gastrointestinal Cancer, 2022;53(1)

11.KAYADİBİ YASEMİN, KOÇAK BURAK, UÇAR NEŞE, AKAN YEŞİM NAMDAR, YILDIRIM EMİNE, BEKTAŞ SİBEL. MRI Radiomics of Breast Cancer: Machine Learning-Based Prediction of Lymphovascular Invasion Status. Academic Radiology, 2022;29(1), 126-134.

12.YILDIRIM EMİNE, UÇAR NEŞE, YETİŞ FIRAT, KAYADİBİ YASEMİN, BEKTAŞ SİBEL. Diagnostic performance of breast imaging with ultrasonography, magnetic resonance and mammography in the assessment of residual tumor after neoadjuvant chemotherapy in breast cancer patients. Journal of Surgery and Medicine, 2022;6(1), 43-48

13.YILDIRIM EMİNE, BEKTAŞ SİBEL, GÖKTAŞ AYDIN SABİN, ER AHMET MUZAFFER, YANIK İREM, ÖZKAN GÜMÜŞKAYA PERİHAN, YILMAZ BARBAROS UTKU, BİLİCİ AHMET, ÖNCEL MUSTAFA. Factors Predicting Response to Neoadjuvant Chemotherapy in Locally Advanced Gastric Cancer. Journal of Istanbul Faculty of Medicine / İstanbul Tıp Fakültesi Dergisi, 2022;85(1), 41-50. 

14.YILDIRIM EMİNE, Pelen Zekeriya, KEĞİN MURAT, UÇAR NEŞE, KAYADİBİ YASEMİN, GÜNDOĞAR ÖZGECAN. Evaluation of the Reliability of Preoperative Ultrasonography and Ultrasonography-Guided Fine Needle Aspiration Biopsy in Axillary Staging in Patients With Breast Cancer. Journal of Academic Research in Medicine, 2021;11(3), 269-276., 

15. KAYADİBİ YASEMİN, UÇAR NEŞE, KAYA MEHMET FATİH, YILDIRIM EMİNE, BEKTAŞ SİBEL. Characterization of Suspicious Microcalcifications on Mammography Using 2D Shear-Wave Elastography. Ultrasound in Medicine & Biology, 2022;47(9), 2532-2542. 

16.KAYADİBİ YASEMİN, TEKCAN ŞANLI DENİZ ESİN, UÇAR NEŞE, YILDIRIM EMİNE, ŞANLI AHMET NECATİ. Evaluation of the Appearance Characteristics of Suspicious Microcalcifications Detected by Ultrasonography. Journal of Academic Research in Medicine, 2022;11(2), 199-205. 

17.YILDIRIM EMİNE, ÖZER HİLAL, ÖZER İLTER, KOYUNCU ADİL, YILDIRIM TİMUR. The Effects on Bacterial Translocation and Tissue Damage of Selenium Treatment in an Experimental Intestinal Ischaemia-Reperfusion Model. Turkish Journal of Trauma and Emergency Surgery, 2021;27(4), 389-394. 

18.YILDIRIM EMİNE, AKBAŞ PELİN, ORHUN ERDOĞAN KIVILCIM, BEKTAŞ SİBEL, ÖZKAN GÜMÜŞKAYA PERİHAN, ER AHMET MUZAFFER, PALTURA CEKİ. The comparison of the histopathological results of the thyroid fine-needle aspiration biopsies in the 795 patients with thyroidectomy. Diagnostic Cytopathology, 2021

Education and Specialization

• Faculty of Medicine, Hacettepe University
• 1999 - Akdeniz University, Faculty of Internal Medicine, Internal Medicine Specialization Training
• Internal Medicine Specialization Training in the USA, Akdeniz University (2013 - 2014)
• Internal Medicine Specialization Training in the USA (2013 - 2014) - Medical Oncology Department
• Akdeniz University, Faculty of Medicine, Department of Medical Oncology (Received Associate Professorship title)

Work Experience

• 2009 - Kayseri Training and Research Hospital, Hospital
• Acıbadem Kayseri
• 2017 - 2018 - Lara Private Anadolu Hospital
• 2018 - Medical Park Antalya Hospital Complex

Expertise

• Diagnosis of organ tumors
• Chemotherapy in cancer treatment
• Targeted cancer therapies
• Immunotherapy in cancer treatment
• Next-generation genetic research in cancer treatment
• Complementary medicine in cancer treatment
• Medical oncology

Education

09 / 2004 – 07 / 2006                Movie Director School, ANT1 Movie School Athens, Greece, Degree “Television Director”, grade point average: B

09 / 2006 – 08 / 2008                Medical School, Semmelweis University Budapest, Hungary, Medical preliminary examination (Physikum), grade point average: A

10 / 2008 – 05 / 2013                Medical School, Albert-Ludwigs-Universität Freiburg, Germany, State examination in medicine, grade point average: A

02/ 2009 – 02/2012                   Institute of Pharamcology and Toxicology I, Albert-Ludwigs-Universität Freiburg, Germany, Doctoral thesis, grade: summa cum laude

05 / 2018                                      Basic and advanced course in German drug law and GCP, Clinical Trials Unit, Medical Center - University of Freiburg

01 / 2019                                      Board certification: Radiotherapy and Radiation Oncology

03 / 2020                                      Medical Center University of Freiburg, Department of Radiation Oncology, Germany, Habilitation (Postdoctoral lecture qualification)

09 / 21 – 08 / 23                         MHBA, Friedrich Alexander University, Nuernberg, Germany

07 / 2022                                      Completion of ISO 9001:2015 training, Nicosia, Cyprus

Professional Career

09 / 2013 – 01 / 2019               Medical Center University of Freiburg, Department of Radiation Oncology, Germany, Residency                                                

07 / 2017 – 07 / 2020               Bertha-Ottenstein programme, Medical Center, University of Freiburg, Germany, Clinician Scientist

Since 06 / 2019                          Medical Center University of Freiburg, Department of Radiation Oncology, Germany, Consultant

01 / 2021 – 12 / 2022                Bertha-Ottenstein programme, Medical Center, University of Freiburg, Germany, Advanced Clinician Scientist

01 / 2021 – 12 / 2021                 Head of the section “Interventional Radiation Oncology”, Medical Center University of Freiburg, Department of Radiation Oncology, Germany

Since 01 / 2022                         Medical Center University of Freiburg, Department of Radiation Oncology, Germany, Prostate cancer research group leader

Since 01 / 2022                          German Medical Institute, Limassol, Cyprus, Vice Medical Director

Professional Memberships and Distinctions

2010           Sanofi-Aventis poster prize, Annual meeting of the German Society of Pharmacology and Toxicology 2010, Mainz, Germany      

2017           Poster prize, Annual meeting of the German Society of Radiation Oncology (DEGRO) 2017, Berlin, Germany

2019           Poster prize, Uro-Oncological Symposium 2019, Magdeburg, Germany

2020           Invited member of the German expert panel for prostate cancer of the German Society of Radiation Oncology (DEGRO)

2020           Herman-Holthusen Award, German Society of Radiation Oncology (DEGRO)

2021           Invited member of the ESTRO-ACROP guideline committee for prostate cancer

2021           Best Abstract, EMUC congress 2021, Athens, Greece

2023           Annual ARO study price for the HypoFocal-SBRT study from the German Cancer Foundation

2023           Invited member of the ESTRO focus group “Urology”

• Education: 
•  
• 2001-2007: University of Ioannina Medical School, Greece.
• 2007: Degree in Medicine.
• 2013: Doctoral degree from the Medical School of the Johann Wolfgang Goethe University, Frankfurt (Dr. Med)
• 09.2016 – Today: Master’s in Healthcare Business Studies.

Professional experience:

04.2009 – 04.2013: Resident in the Department for Radiation Oncology, Klinikum Offenbach

05.2013 – 12. 2015: Senior physician in the Department for Radiation Oncology, Klinikum Offenbach

• 01.2016 – 06.2017: Senior physician in the Department of interventional Radiation Oncology, Medical Center Athens
•  
• 07.2017 – Today: Head of the Department of Radiation Oncology at the German Oncology Center, Limassol, Cyprus.

Dr. Yuri Goldes is a general surgeon with more than 20 years of clinical experience. He specializes in upper gastrointestinal and oncologic surgery. He is Deputy Director of the Department of General Surgery and Transplantation at Sheba Medical Center in Tel Aviv. He also leads the Upper GI Surgery Unit. He was named to Forbes Israel’s Best Doctors in 2025. He is ranked among Israel’s Best Gastrointestinal Surgeons by Forbes. In 2019, he received the Israeli Ministry of Health “Best Doctor of the Year” award.

He is an expert in advanced minimally invasive and robotic surgery. He treats diaphragmatic hernia, achalasia, GERD, and gallbladder disease. He also performs oncologic surgery for pancreatic, gastric, and esophageal cancers. He uses laparoscopic and robotic techniques.

He pioneered some of Israel’s first robotic oncologic resections of the stomach and pancreas. He is among a small group worldwide who perform minimally invasive Whipple procedures (pancreaticoduodenectomy) using advanced laparoscopy. He applies methods that improve outcomes and speed recovery. He provides personalized care.

グラウペラ博士は受賞歴のある小児腫瘍医であり、骨および軟部組織肉腫の名医の一人です。 サンジョアン・デ・デウ病院の血液腫瘍科を率いており、同病院はヨーロッパ屈指の子供病院です。 研究者。 米国で訓練を受けました。

専門分野

神経芽細胞腫、神経膠腫、ユーイング肉腫、ウィルムス腫瘍の治療を提供します。

職務経験

• サンジョアン・デ・デウ — バルセロナ児童病院の血液腫瘍科の科学ディレクター
• サンジョアン・デ・デウ — バルセロナ児童病院の発達腫瘍研究所のディレクター。

教育

• 1990 — バルセロナ大学の医学と健康科学の学部 — 一般医学と外科の学位
• 1995 — バル・ダル・ヘブロン大学病院 — 小児科専門
• 1996-1999 — コーネル医科大学とメモリアル・スローン・ケタリングがんセンター（米国） — 小児血液腫瘍学のフェローシップ
• 1999-2001 — メモリアル・スローン・ケタリングがんセンター（米国） — 小児がんの分子病理学のフェローシップ
• 2003 — バルセロナ自治大学 — 医学博士号。

受賞歴

• 2000 — アメリカ臨床腫瘍学会からの若手研究者賞
• 2001 — 国際小児腫瘍学会からのシュバイスグット賞、小児腫瘍学における最優秀科学論文に対して
• 2001 — アメリカ臨床腫瘍学会からのキャリア開発賞
• 2006 — スペイン癌研究協会（AECC）による子供の癌研究に関する第一賞
• 2011 — BBVA財団賞、科学研究における小児がんへの顕著な貢献に対して
• 2001 — 国際小児腫瘍学会からのシュバイスグット賞、小児腫瘍学における最優秀科学論文に対して。

科学活動

ジャウメ・モラ・グラウペラ博士は、子供の悪性腫瘍治療に関する70以上の論文を執筆しています。 放射線療法を用いない脊髄神経膠腫に対する受動的治療法を開発しました。

組織のメンバーシップ

• 国際小児腫瘍学会（SIOP）
• アメリカ臨床腫瘍学会
• アメリカがん研究協会
• スペイン小児血液腫瘍学会
• カタルーニャ小児科学会
• ヒスチオサイト協会。

Experience

2022 PRIVATE MEDIPOL BAHÇELİEVLER HOSPITAL

2021 - 2021 Prof. Dr. Cemil Taşçıoğlu City Hospital, Medical Oncology Clinic Education Officer

2021 - 2021 Prof. Dr. Cemil Taşçıoğlu City Hospital

2020 - 2021 Yüzüncü Yıl University Faculty of Medicine

2020 - 2021 Head of the Department of Medical Oncology, Yüzüncü Yıl University Faculty of Medicine, Assoc. Dr.  

2018 - 2021 Lecturer - Yüzüncü Yıl University Faculty of Medicine, Head of Medical Oncology Department  

2018 - 2021 Yüzüncü Yıl University Faculty of Medicine

2015 - 2018 University of Health Sciences, Okmeydanı Training and Research Hospital

2015 - 2018 University of Health Sciences, Okmeydanı Training and Research Hospital, Medical Oncology Clinic, Sub-branch assistant

2012 - 2015 Kanuni Sultan Süleyman Training and Research Hospital, Internal Medicine specialist

2012 - 2015 Suleiman the Magnificent Training and Research Hospital,

2008 - 2012 Haseki Training and Research Hospital

2006 - 2008 Kızıltepe No. 3 Health Center General Practitioner.

Education

2018

İstanbul Okmeydanı Eğitim ve Araştırma Hastanesi, Tıbbı Onkoloji

2018

İstanbul Okmeydanı Eğitim ve Araştırma Hastanesi, Tıbbı Onkoloji, İstanbul Okmeydanı Eğitim ve Araştırma Hastanesi, Tıbbı Onkoloji

2012

İstanbul Haseki Eğitim ve Araştırma Hastanesi, İç Hastalıkları, İstanbul Haseki Eğitim ve Araştırma Hastanesi, İç Hastalıkları

2012

İstanbul Haseki Eğitim ve Araştırma Hastanesi, İç Hastalıkları

2007

Uludağ Üniversitesi Tıip Fakültesi, Tıip Fakültesi, Uludağ Üniversitesi Tıip Fakültesi, Tıip Fakültesi

シナン・カラアスラン医師は、アナドル医療センターにおいて、乳房・大腸・泌尿生殖器系の悪性腫瘍を専門とし、900件以上の処置を行ってきました。

• 腫瘍内科専門医資格を取得し、29年の経験の専門的な診療経験を有する
• トルコ腫瘍内科学会および肺癌学会の会員
• イスタンブール大学チェラフパシャ医学部にてフェローシップ研修を修了
• 複雑症例に対する免疫療法および分子標的療法の専門家